Literature DB >> 16439556

Genetic identification of adenovirus type 5 genes that influence viral spread.

T Subramanian1, S Vijayalingam, G Chinnadurai.   

Abstract

The mechanisms that control cell-to-cell spread of human adenoviruses (Ad) are not well understood. Two early viral proteins, E1B-19K and E3-ADP, appear to have opposing effects since viral mutants that are individually deficient in E1B-19K produce large plaques (G. Chinnadurai, Cell 33:759-766, 1983), while mutants deficient in E3-ADP produce small plaques (A. E. Tollefson et al., J. Virol. 70:2296-2306, 1996) on infected cell monolayers. We have used a genetic strategy to identify different viral genes that influence adenovirus type 5 (Ad5) spread in an epithelial cancer cell line. An Ad5 mutant (dl327; lacking most of the E3 region) with the restricted-spread (small-plaque) phenotype was randomly mutagenized with UV, and 27 large-plaque (lp) mutants were isolated. A combination of analyses of viral proteins and genomic DNA sequences have indicated that 23 mutants contained lesions in the E1B region affecting either 19K or both 19K and 55K proteins. Four other lp mutants contained lesions in early regions E1A and E4, in the early L1 region that codes for the i-leader protein, and in late regions that code for the viral structural proteins, penton base, and fiber. Our results suggest that the requirement of E3-ADP for Ad spread could be readily compensated for by abrogation of the functions of E1B-19K and provide genetic evidence that these two viral proteins influence viral spread in opposing manners. In addition to E1B and E3 proteins, other early and late proteins that regulate viral replication and infectivity also influence lateral viral spread. Our studies have identified novel mutations that could be exploited in designing efficient oncolytic Ad vectors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16439556      PMCID: PMC1367173          DOI: 10.1128/JVI.80.4.2000-2012.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  84 in total

1.  Nuclear envelope localization of an adenovirus tumor antigen maintains the integrity of cellular DNA.

Authors:  E White; S H Blose; B W Stillman
Journal:  Mol Cell Biol       Date:  1984-12       Impact factor: 4.272

2.  Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector.

Authors:  H Sauthoff; S Heitner; W N Rom; J G Hay
Journal:  Hum Gene Ther       Date:  2000-02-10       Impact factor: 5.695

3.  Role of vesicles during adenovirus 2 internalization into HeLa cells.

Authors:  U Svensson
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

4.  Human adenovirus 2 E1B-19K and E1B-53K tumor antigens: antipeptide antibodies targeted to the NH2 and COOH termini.

Authors:  M Green; K H Brackmann; L A Lucher; J S Symington; T A Kramer
Journal:  J Virol       Date:  1983-12       Impact factor: 5.103

5.  19-kDa tumor antigen coded by early region E1b of adenovirus 2 is required for efficient synthesis and for protection of viral DNA.

Authors:  T Subramanian; M Kuppuswamy; J Gysbers; S Mak; G Chinnadurai
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

6.  Role of a low-pH environment in adenovirus enhancement of the toxicity of a Pseudomonas exotoxin-epidermal growth factor conjugate.

Authors:  P Seth; D J Fitzgerald; M C Willingham; I Pastan
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

7.  cyt gene of adenoviruses 2 and 5 is an oncogene for transforming function in early region E1B and encodes the E1B 19,000-molecular-weight polypeptide.

Authors:  N Takemori; C Cladaras; B Bhat; A J Conley; W S Wold
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

8.  Mutations in the gene encoding the adenovirus early region 1B 19,000-molecular-weight tumor antigen cause the degradation of chromosomal DNA.

Authors:  E White; T Grodzicker; B W Stillman
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

9.  Deletion of the gene encoding the adenovirus 5 early region 1b 21,000-molecular-weight polypeptide leads to degradation of viral and host cell DNA.

Authors:  S Pilder; J Logan; T Shenk
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

10.  Adenovirus cyt+ locus, which controls cell transformation and tumorigenicity, is an allele of lp+ locus, which codes for a 19-kilodalton tumor antigen.

Authors:  T Subramanian; M Kuppuswamy; S Mak; G Chinnadurai
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

View more
  32 in total

1.  Verapamil enhances the antitumoral efficacy of oncolytic adenoviruses.

Authors:  Alena Gros; Cristina Puig; Sonia Guedan; Juan José Rojas; Ramon Alemany; Manel Cascallo
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

2.  Identification of integrin alpha3 as a new substrate of the adenovirus E4orf6/E1B 55-kilodalton E3 ubiquitin ligase complex.

Authors:  Frédéric Dallaire; Paola Blanchette; Peter Groitl; Thomas Dobner; Philip E Branton
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

3.  Adeno-associated virus enhances wild-type and oncolytic adenovirus spread.

Authors:  Eduardo Laborda; Cristina Puig-Saus; Manel Cascalló; Miguel Chillón; Ramon Alemany
Journal:  Hum Gene Ther Methods       Date:  2013-10-08       Impact factor: 2.396

4.  Down-regulation of multiple cell survival proteins in head and neck cancer cells by an apoptogenic mutant of adenovirus type 5.

Authors:  S Vijayalingam; T Subramanian; Jan Ryerse; Mark Varvares; G Chinnadurai
Journal:  Virology       Date:  2009-07-24       Impact factor: 3.616

5.  Adenovirus i-leader truncation bioselected against cancer-associated fibroblasts to overcome tumor stromal barriers.

Authors:  Cristina Puig-Saus; Alena Gros; Ramon Alemany; Manel Cascalló
Journal:  Mol Ther       Date:  2011-08-23       Impact factor: 11.454

6.  Anticancer activity of oncolytic adenovirus vector armed with IFN-alpha and ADP is enhanced by pharmacologically controlled expression of TRAIL.

Authors:  E V Shashkova; M N Kuppuswamy; W S M Wold; K Doronin
Journal:  Cancer Gene Ther       Date:  2007-11-09       Impact factor: 5.987

7.  The combination of i-leader truncation and gemcitabine improves oncolytic adenovirus efficacy in an immunocompetent model.

Authors:  C Puig-Saus; E Laborda; A Rodríguez-García; M Cascalló; R Moreno; R Alemany
Journal:  Cancer Gene Ther       Date:  2014-01-17       Impact factor: 5.987

8.  Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.

Authors:  Han Hsi Wong; Nicholas R Lemoine; Yaohe Wang
Journal:  Viruses       Date:  2010-01       Impact factor: 5.818

9.  Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer.

Authors:  S K Baird; J L Aerts; A Eddaoudi; M Lockley; N R Lemoine; I A McNeish
Journal:  Oncogene       Date:  2007-12-10       Impact factor: 9.867

10.  Unique sequence features of the Human adenovirus 31 complete genomic sequence are conserved in clinical isolates.

Authors:  Soeren Hofmayer; Ijad Madisch; Sebastian Darr; Fabienne Rehren; Albert Heim
Journal:  BMC Genomics       Date:  2009-11-25       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.